PH21444A - Erythro-(e)-7-(3'-c1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept- 6-enoic acids and derivatives thereof - Google Patents

Erythro-(e)-7-(3'-c1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept- 6-enoic acids and derivatives thereof

Info

Publication number
PH21444A
PH21444A PH32550A PH32550A PH21444A PH 21444 A PH21444 A PH 21444A PH 32550 A PH32550 A PH 32550A PH 32550 A PH32550 A PH 32550A PH 21444 A PH21444 A PH 21444A
Authority
PH
Philippines
Prior art keywords
dihydroxyhept
3alkyl
erythro
naphth
dimethylphenyl
Prior art date
Application number
PH32550A
Other languages
English (en)
Inventor
Paul L Anderson
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PH21444A publication Critical patent/PH21444A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C07C57/40Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic containing condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
PH32550A 1984-07-24 1985-07-22 Erythro-(e)-7-(3'-c1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept- 6-enoic acids and derivatives thereof PH21444A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63380984A 1984-07-24 1984-07-24

Publications (1)

Publication Number Publication Date
PH21444A true PH21444A (en) 1987-10-20

Family

ID=24541204

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32550A PH21444A (en) 1984-07-24 1985-07-22 Erythro-(e)-7-(3'-c1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept- 6-enoic acids and derivatives thereof

Country Status (21)

Country Link
JP (1) JPS6137754A (it)
KR (1) KR860001045A (it)
AU (1) AU4522685A (it)
BE (1) BE902914A (it)
DE (1) DE3525256A1 (it)
DK (1) DK333785A (it)
ES (1) ES8705356A1 (it)
FI (1) FI852851L (it)
FR (1) FR2568248A1 (it)
GB (1) GB2162179A (it)
GR (1) GR851805B (it)
HU (1) HUT39142A (it)
IL (1) IL75874A0 (it)
IT (1) IT1200095B (it)
LU (1) LU86012A1 (it)
NL (1) NL8502010A (it)
PH (1) PH21444A (it)
PL (1) PL254654A1 (it)
PT (1) PT80845B (it)
SE (1) SE8503556L (it)
ZA (1) ZA855594B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904646A (en) * 1987-05-22 1990-02-27 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-COA reductase inhibitors
US5091378A (en) * 1987-05-22 1992-02-25 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
DE3722807A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Neue 3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
US4792614A (en) * 1987-08-05 1988-12-20 American Home Products Corporation Substituted furans as inhibitors of 3-hydroxy-3-methylglutaryl-coa reductase
US4812583A (en) * 1987-09-11 1989-03-14 American Home Products Corporation Substituted acyloxyalkylphenylethylene inhibitors of 3-hydroxy-3-methylglutaryl-coa reductase
DE3818570A1 (de) * 1988-06-01 1989-12-21 Boehringer Mannheim Gmbh Neue 6-substituierte-4-hydroxy-tetrahydro-pyran -2-on-derivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen
US5506219A (en) * 1988-08-29 1996-04-09 E. R. Squibb & Sons, Inc. Pyridine anchors for HMG-CoA reductase inhibitors
CA2185961A1 (en) * 1996-09-19 1998-03-20 K.S. Keshava Murthy Process for producing simvastatin
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
KR100836960B1 (ko) 2007-09-07 2008-06-10 주식회사 서울제약 새로운 나이아신 제어방출형 제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55132595A (en) * 1979-04-04 1980-10-15 Nec Corp Semiconductor circuit

Also Published As

Publication number Publication date
LU86012A1 (fr) 1986-02-12
SE8503556L (sv) 1986-01-25
JPS6137754A (ja) 1986-02-22
DK333785A (da) 1986-01-25
ES8705356A1 (es) 1987-05-01
PT80845B (en) 1987-03-24
PT80845A (en) 1985-08-01
IT1200095B (it) 1989-01-05
GR851805B (it) 1985-11-26
IL75874A0 (en) 1985-11-29
FR2568248A1 (fr) 1986-01-31
PL254654A1 (en) 1986-08-26
IT8548385A0 (it) 1985-07-23
GB8518490D0 (en) 1985-08-29
AU4522685A (en) 1986-01-30
DE3525256A1 (de) 1986-01-30
ES545454A0 (es) 1987-05-01
NL8502010A (nl) 1986-02-17
FI852851A0 (fi) 1985-07-22
KR860001045A (ko) 1986-02-22
BE902914A (fr) 1986-01-17
FI852851L (fi) 1986-01-25
DK333785D0 (da) 1985-07-22
GB2162179A (en) 1986-01-29
HUT39142A (en) 1986-08-28
SE8503556D0 (sv) 1985-07-22
ZA855594B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
DE3665456D1 (en) Pyrimidine derivatives
GR3001555T3 (en) 4(4-oxo-1,4-dihydropyridin-1-yl)phenyl derivatives
GB2158825B (en) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof
DE3473875D1 (en) Pyrimidine derivatives, preparation thereof and use thereof
EP0257850A3 (en) Pyrimidine derivatives
EP0169712A3 (en) New pyrimidine derivatives, processes for preparation thereof and composition containing the same
PT84010A (en) Pyrimidine derivatives
PH21444A (en) Erythro-(e)-7-(3'-c1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept- 6-enoic acids and derivatives thereof
EP0177287A3 (en) Pyrimidine derivatives, processes for preparation thereof and composition of the same
IL74133A0 (en) Azolyl-aryl-alkanol derivatives,processes for their preparation and their use
ZA869588B (en) 5,6-dialkoxy-4-imino-2(1h)quinazolinone derivatives
ZA864888B (en) 5-substituted-6-aminopyrimidine derivatives,composition and uses
HK1003112A1 (en) 5-fluorouracil derivatives
EP0150984A3 (en) 6-(substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof
ZA85682B (en) 6-(substituted)methylenepenicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
GB8417852D0 (en) Pyrimidine derivatives
ZA865426B (en) Antihypertensive agents
ZA856886B (en) Antihypertensive derivatives
EP0166564A3 (en) Pyrimidone derivatives, preparation thereof and use thereof
ZA841839B (en) Pyrimidine derivatives,preparation thereof and use thereof
GB8706972D0 (en) 5-fluorouracil derivatives
GB8618196D0 (en) Antihypertensive agents
GR861916B (en) Antihypertensive agents
GB8505286D0 (en) Quinoxaline derivatives
ZA855369B (en) New pyrimidine derivatives,processes for preparation thereof and composition containing the same